Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Total Non-Current Liabilities (2016 - 2025)

Sanofi (SNY) has disclosed Total Non-Current Liabilities for 11 consecutive years, with $31.1 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 13.04% to $31.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.1 billion through Dec 2025, up 13.04% year-over-year, with the annual reading at $30.2 billion for FY2025, 8.32% up from the prior year.
  • Total Non-Current Liabilities hit $31.1 billion in Q4 2025 for Sanofi, up from $27.5 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $34.2 billion in Q4 2021 to a low of $27.5 billion in Q4 2024.
  • Historically, Total Non-Current Liabilities has averaged $30.2 billion across 5 years, with a median of $30.0 billion in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: fell 17.73% in 2022 and later increased 13.04% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $34.2 billion in 2021, then dropped by 17.73% to $28.2 billion in 2022, then increased by 6.64% to $30.0 billion in 2023, then fell by 8.25% to $27.5 billion in 2024, then increased by 13.04% to $31.1 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for SNY at $31.1 billion in Q4 2025, $27.5 billion in Q4 2024, and $30.0 billion in Q4 2023.